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CHAPTER 3
Synthesis of Unmodified Oligonucleotides
INTRODUCTION
B ecause of the significant progress achieved in the chemical synthesis of oligonu-cleotides during the past four decades, synthetic oligonucleotides have become read-
ily available and have fueled the biotechnology revolution that has irreversibly changed
biomedical research and the pharmaceutical industry. For example, without the ability to
rapidly and efficiently synthesize DNA oligonucleotides, the development of the poly-
merase chain reaction (PCR) and its multiple applications would have been difficult, if
not impossible, because this technology is completely dependent upon the use of DNA
primers. Similarly, the availability of synthetic oligonucleotides has been instrumental
in the development of automated DNA sequencing, which is also dependent on the use
of DNA primers. An important biological application of synthetic oligonucleotides re-
lates to site-specific mutagenesis of genes. Mutagenesis of this type has been utilized to
study protein structure-function relationships, and to alter the therapeutic spectrum of
pharmaceutically active proteins. Synthetic oligonucleotides have also found application
as diagnostic hybridization probes and, more recently, in the use of DNA chips for high-
throughput detection of genetic diseases and identification of genomic single-nucleotide
polymorphisms. Furthermore, the availability of synthetic RNA oligonucleotides has led
to the preparation of ribozymes, which are RNAs with catalytic activity. In this regard, it
is being speculated that RNA may have been the primary self-replicating molecule from
which life originated. Collectively, themultiple biomedical applications of syntheticDNA
and RNA oligonucleotides are a direct measure of the colossal impact the methods for
rapid and efficient preparation of these biomolecules have had on the life sciences.
Like Chapter 2, this chapter is composed of a number of overviews that provide investiga-
tors with a fundamental knowledge of solid-phase oligonucleotide synthesis, as well as a
number of step-by-step protocols delineating the preparation of various oligonucleotides
from suitably protected nucleoside phosphoramidite or H-phosphonate derivatives.
UNIT 3.1 browses through the physical and chemical properties of liquid-phase and solid-
phase supports that have been developed over the years, and compares their suitability for
oligonucleotide synthesis. The unit also examines the properties of linkers for transient
or permanent attachment of properly protected nucleosides to the derivatized support of
interest. Conditions for the release of synthetic oligonucleotides from specific supports
have been discussed in detail. A step-by-step protocol for the attachment of nucleosides to
commonly functionalized supports via either a succinyl or a hydroquinone-O,O′-diacetyl
linker is provided in UNIT 3.2.
Solid-phase synthesis of oligonucleotides is governed by a number of parameters. For
example, UNIT 3.3 reviews the mechanism of activation of deoxyribonucleoside phospho-
ramidites, the type of activators required for such activation, and the consequences of an
activator’s acidity on the production of synthetic oligonucleotides. Steric factors affecting
the condensation rates of deoxyribonucleoside phosphoramidites and the significance of
“capping” and oxidation reactions in the chemical synthesis of oligonucleotides, along
with oligonucleotide deprotection strategies, are discussed at length in the unit. Finally,
UNIT 3.3 deals with the application of dinucleotide and trinucleotide phosphoramidites
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as alternatives to monomeric deoxyribonucleoside phosphoramidites in the synthesis of
DNA oligonucleotides.
Additional synthetic strategies and parameters related to the synthesis of oligodeoxyribo-
and oligoribonucleotides according to theH-phosphonatemethod are discussed inUNIT 3.4.
An optimized synthetic protocol for oligoribonucleotide synthesis is described to further
validate the potential of the method.
The chemical synthesis of DNA oligonucleotides without nucleobase protection has been
and is still an elusive goal. An overview of the strategies that have been developed so far
to achieve this goal is presented in UNIT 3.10.
Strategies in the selection of N-, 5′-O-, and 2′-O-protecting groups for efficient synthe-
sis of oligoribonucleotides according to the phosphoramidite approach are discussed in
depth in UNIT 3.5. Critical synthesis parameters such as the type of support being used
and selection of the optimal activator for ribonucleoside phosphoramidites, as well as
oligonucleotide deprotection protocols, are also reviewed in the unit to provide a com-
prehensive account of RNA phosphoramidite chemistry. As a logical extension of UNIT 3.5,
the solid-phase synthesis of oligoribonucleotides with 2′-O-tert-butyldimethylsilyl, 2′-
O-(2-nitrobenzyloxymethyl), or 2′-O-[(triisopropylsilyl)oxy]methyl groups according to
the phosphoramidite approach is delineated in UNITS 3.6-3.8, respectively, along with de-
tailed methods for the deprotection of these oligonucleotides.
In future supplements, this chapter will also incorporate step-by-step protocols describing
new methods for the synthesis of unmodified DNA oligonucleotides that employ either
new phosphate-protecting groups or novel coupling procedures to accommodate specific
nucleic acid applications. In this regard, the use of 3-(N-tert-butylcarboxamido)-1-propyl
and 4-oxopentyl groups for phosphate/thiophosphate protection in solid-phase DNA syn-
thesis is presented in UNIT 3.9, along with that of the 4-methylthio-l-butyl group in UNIT 3.11.
These protecting groups may find application in large-scale preparations of therapeutic
oligonucleotides. Likewise, oligoribonucleotide synthesis protocols comparing the prop-
erties of selected 2′-O-protecting groups, coupling methods, and deprotection conditions
will be included in an effort to contribute the best nucleic acid tools to investigators
pushing further the frontiers of knowledge.
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